Over the last 90 days, prior to the date of this filing, there have been 22 insider transactions reported to the SEC for Veracyte. These transactions came from the activities of 4 individual insiders that resulted in a net acquisition of 12,337 company shares. This compares with the preceding 90-day window of time where there were 19 transactions from 7 insiders which resulted in the net acquisition of 22,030 shares.
This is a lower level of transactions than the peer group average in the 10-company Bio Diagnostics & Testing peer group over the last 90-day period. Peer group activity averaged 40.8 transactions per company, with company insiders acquiring on average 244,209 shares.
SEC Story Link http://www.sec.gov/Archives/edgar/data/1384101/000138410119000152/xslF345X03/wf-form4_157549452516750.xml
|Q4, 2019, and 2020 Earnings Estimates for WellCare H...|
|2019, 2020 Earnings Estimates for Wabash National Sc...|
|Forecast for Valero Energy's Q4 and Full Year Earnin...|
|Analysts Scale Back VF Corp's Q4, 2020, and 2021 Ear...|
|Univest Financial's 2020, 2021, and Q1 Earnings Esti...|